About
About VCPHCS IX LLC BHG Nashville Treatment Center
BHG Nashville Treatment Center, listed in SAMHSA records under its parent entity VCPHCS IX LLC, is one of Behavioral Health Group’s 110-plus accredited treatment centers across more than 20 states. The Nashville location is at 342 22nd Avenue North in Davidson County, just north of Music Row and within easy reach of downtown Nashville. The clinic operates as a SAMHSA-certified Opioid Treatment Program (OTP) and is accredited by the Joint Commission.
Care is delivered through outpatient and intensive outpatient programming, anchored in Medications for Opioid Use Disorder (MOUD). BHG clinicians prescribe and, where appropriate, dispense methadone, buprenorphine, and naltrexone as part of a comprehensive plan that pairs medication with behavioral counseling. The website reports outcomes that the company describes as industry-leading, including high reductions in substance use and improved patient quality of life. Same-day access is offered for patients who walk in or call ready to begin care.
The Nashville center treats opioid use disorder, broader substance use disorder, and co-occurring mental health conditions, including challenges related to fentanyl, heroin, prescription opioids, and emerging substances such as kratom, 7-OH, and tianaa/tianeptine. Behavioral counseling is layered alongside MOUD to address triggers, relapse prevention, and the trauma that often underlies addiction. Cognitive Behavioral Therapy is documented as the program’s evidence-based modality.
BHG’s clinical leadership is publicly listed, including Chief Medical Officer Benjamin Nordstrom, MD, PhD; Chief Clinical Officer Kamala Greene Genece, PhD; Senior Vice President of Regulatory Affairs Marlin Martin, CHC, MSW, LCSW, ICSW, CHPSE; and Vice President of Operations Amanda Karistai, MBA, LCSW-BACS. Insurance coverage is broad, including TRICARE, Medicare Parts A and B, Medicaid, Kaiser (MD and VA residents only), MA Aetna, MA Humana, and MA United Healthcare/Optum. Patients without insurance can ask about grant funding and sliding-scale support during intake.
- Specialized opioid detox protocols for fentanyl, heroin, prescription opioids, kratom, and tianeptine withdrawal
- Joint Commission accreditation ensures quality medical detox standards and withdrawal management protocols
- FDA-approved MOUD including methadone, buprenorphine, and naltrexone administered under medical supervision
- Early morning hours starting at 5:30 AM accommodate work schedules during outpatient detox treatment
- American Sign Language interpretation services available for deaf and hearing-impaired patients